Bone morphogenetic protein 6: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 05:03, 17 March 2025
Bone morphogenetic protein 6 (also known as BMP6) is a protein that in humans is encoded by the BMP6 gene. BMP6 belongs to the transforming growth factor beta (TGF-beta) superfamily, a group of proteins involved in the regulation of cellular processes.
Function[edit]
BMP6, like other bone morphogenetic proteins, plays a key role in the development of bone and cartilage. It is involved in a variety of biological processes including cell growth, apoptosis, morphogenesis, cell differentiation, and immune response. BMP6 is also implicated in the Wnt signaling pathway, a complex network of proteins crucial for embryonic development.
Clinical significance[edit]
Alterations in the BMP6 gene have been associated with a variety of diseases. For instance, mutations in this gene have been linked to osteoporosis, a condition characterized by low bone mass and deterioration of bone tissue. Additionally, BMP6 has been implicated in cancer development and progression, particularly in breast cancer and prostate cancer.
Structure[edit]
The BMP6 protein is a dimeric molecule, consisting of two identical subunits. Each subunit is composed of a large extracellular domain, a single transmembrane domain, and a short cytoplasmic domain. The extracellular domain is responsible for binding to specific receptors on the cell surface, initiating the signal transduction pathway.
See also[edit]
References[edit]
<references />

